Media Advisory: GenSpera 2014 BIO International

New Post Public Reply Private Reply Replies (0) Message Board
Jerseyfish
Media Advisory: GenSpera 2014 BIO International Presentation Available
Date : 06/30/2014 @ 8:00AM
Source : PR Newswire (US)
Stock : Genspera (QB) (GNSZ)
Quote : 0.94 0.0 (0.00%) @ 7:54AM

Media Advisory: GenSpera 2014 BIO International Presentation Available
Print
Alert
Genspera (QB) (USOTC:GNSZ)
Intraday Stock Chart

Today : Monday 30 June 2014
Click Here for more Genspera (QB) Charts.

SAN ANTONIO, June 30, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the 2014 BIO International presentation by Chairman and CEO, Craig Dionne, PhD from the 2014 BIO International Convention held June 24th in San Diego, California.

Dr. Dionne presented interim results from the Phase Ib and ongoing Phase II study for lead drug candidate, G-202.

Summary:

G-202 Data in Hepatocellular (HCC) Patients (Ph I and Ph II)
All patients previously progressed on, or were intolerant of, sorafenib
Outstanding clinical safety profile
Well tolerated with easily managed and predictable side effects
No effect on bone marrow!
80% of patients with stable disease (no tumor growth) at two months
50% of patients with stable disease for >/= 4 months
Long-term disease stabilization (>/= 9 months) in 15% of patients
One patient remains on treatment > 22 months
End of bone pain in one patient with vertebral metastasis

The full BIO presentation is available for view at:
http://www.genspera.com/press/140620_GNSZ_BIO...4_2014.pdf

About GenSpera
GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. Unlike typical chemotherapeutic agents, thapsigargin results in cell death irrespective of the rate of cell division, which may provide an effective approach to kill both fast- and slow-growing cancers. GenSpera's lead drug candidate, G-202, is activated by the enzyme PSMA, which is found at high levels in the vasculature of liver and glioblastoma cancers and in the vasculature of almost all other solid tumors. G-202 is therefore expected to have potential efficacy in a wide variety of tumor types.

G-202 Phase II clinical trials are underway in both hepatocellular carcinoma and glioblastoma patients.

For more information, please visit the company's website: www.genspera.com or follow us on Twitter @GenSperaNews.

About BIO
The 2014 BIO International Convention was held June 23-26 at the San Diego Convention Center in San Diego, California.

The BIO International Convention was hosted by the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. http://convention.bio.org/2014/

Cautionary Statement Regarding Forward Looking Information
This news release may contain forward-looking statements. Investors are cautioned that statements in this press release regarding potential applications of GenSpera's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties will be detailed from time to time in GenSpera's periodic reports filed with the Securities and Exchange Commission.

CONTACT:

Company: Craig Dionne, PhD, CEO
GenSpera, Inc. +1-210-479-8112

Investors: John Baldissera
BPC Financial Marketing: 800-368-1217

Media: 800-665-0411

SOURCE GenSpera, Inc.

Copyright 2014 PR Newswire

Rebus Hldgs (RBSH) Stock Research Links

RBSH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

3700 Midway Seals $32.5M Deal for Midland Apartments

Updated Category News Views 1

A New Landmark in Midland Midland, Texas just got itself a fresh, shiny addition in the form of a real estate deal worth $32.5 million. On the books as of September 1, 2026, 3700 Midway, LLC has grabbed hold of Midway Station, setting their stakes straight in the heart of Midland's bustling business corridor. The Scope of the Deal This acquisition is more than just a line...

Continue Reading
Union Savings Bank Leverages AI for Strategic Growth

Updated Category News Views 4

USB's Data-Driven Approach Transforms Banking Remember the days of handing out toasters to keep customers? Union Savings Bank (USB) sure doesn't seem to, as it embraces tech-savvy methods to keep its clientele content. Instead, the $3.3 billion community bank based in Danbury, Connecticut, has deployed NGDATA's AI Hub, transforming its approach to reducing customer churn...

Continue Reading
Innventure Faces Class Action Over Alleged Deception

Updated Category News Views 0

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...

Continue Reading
Qingdao-Yerevan Collaboration: New Strategic Heights

Updated Category News Views 1

Qingdao and Yerevan: More Than Just a Port of Call Who would have thought? An Armenian ambassador talking shop in a Chinese port city isn't your everyday headline, but let me tell you, it's big news if you're watching global growth. Armenian Ambassador Vahe Gevorgyan's recent spiel in Qingdao might not turn heads on Wall Street, but there's more under the hood than meets...

Continue Reading
Manulife's $750M US Offering: Risky or Strategic?

Updated Category News Views 2

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Continue Reading
Palmer's Design Fuels Child Cancer Awareness Drive

Updated Category News Views 6

Imagine a cancer struggle fueling creativity – a hopeful story from the racetrack lights up this reality as Valvoline and a young survivor rev up their engines for children with blood cancer. Powerful Partnership Takes Unforgettable Turn Palmer Goforth, a twelve-year-old cancer survivor, never imagined his hobby of drawing sketches would lead to designing a NASCAR car....

Continue Reading
ADA Audit Reveals Gaps in Event Management at 2026 Session

Updated Category News Views 2

Hold onto your hats, folks, because the American Diabetes Association (ADA) just dropped a bombshell report with findings that'll make your head spin if you're keyed into the healthcare sector. They’ve wrapped this up in a bow of accountability, but let's dig into the crux of it. Behind the Controversy: The New Orleans Incident This all harks back to an incident on June...

Continue Reading
California's Annual Recovery Happens Event Unites Community

Updated Category News Views 1

A Public Campaign for Recovery Awareness Anyone with a pulse on what's going on in the addiction recovery landscape knows the significance of events like Recovery Happens. It's not just another day in Sacramento; it's a rallying cry for change—a public affirmation that recovery is tangible and thriving. This isn't about showy gala dinners or fancy corporate events; it's...

Continue Reading
ZPMC Names Two New 38,000 DWT Vessels for Chipolbrok

Updated Category News Views 2

Navigating Uncharted Waters with New Vessels Some days, you see a giant leap in an industry and think, "Well, someone's got ambition." Here, we're talking about ZPMC's gutsy naming ceremony for two spanking new 38,000 DWT multipurpose heavy-lift ships destined for Chipolbrok, happening fresh off the docks in Shanghai. Specifications That Make Waves Imagine a vessel the...

Continue Reading
Aitan Raises $41M to Expand Robotic Warfare Tech

Updated Category News Views 0

Pioneering Sovereign Robotic Warfare The defense sector's landscape is shifting, and Aitan is driving a movement with their 'Robotic Sovereignty-as-a-Service'. Coming out of stealth with a hefty $41 million funding boost, this Israeli-American company is redefining modern warfare's playbook. In today's unpredictable world, traditional combat methods are becoming relics of...

Continue Reading

Top 5 Most Recently Viewed Articles

Exhibitus Unveils EXstudios to Elevate Experiential Marketing

Updated Category News Views 167

Exhibitus Launches EXstudios for Enhanced Engagement Exhibitus has introduced EXstudios, an innovative experiential strategy and creative ideation studio aimed at expanding the company's existing capabilities. This new division places a strong emphasis on experiential storytelling and front-end strategy across various marketing channels. For over three decades, Exhibitus...

Continue Reading
Anticipated Growth of Milk Ingredients Market Through 2034

Updated Category News Views 155

Overview of the Milk Ingredients Market The global milk ingredients market is witnessing a remarkable expansion, with projections indicating an increase to USD 74.7 billion by the end of the year. The compound annual growth rate (CAGR) of 4.9% is anticipated between the current year and 2034. By the conclusion of this period, the market is expected to reach approximately...

Continue Reading
Klear.ai Partners with APRA to Transform Claims Operations

Updated Category News Views 255

Klear.ai Teams Up with APRA for Claims Modernization Klear.ai, a pioneer in intelligence-powered claims and risk solutions, is embarking on a transformative journey alongside the Alaska Public Risk Alliance (APRA). This collaboration is focused on modernizing and unifying claims operations as APRA prepares to consolidate public risk pools, moving away from the separate...

Continue Reading
Why DraftKings (NASDAQ: DKNG) Is an Attractive Investment

Updated Category News Views 237

DraftKings (NASDAQ: DKNG): Promising Investment Insights DraftKings is a leading digital sports betting and iGaming app provider that has experienced significant growth in recent years, although it still faces challenges in achieving profitability. The company has captured a substantial share of the online betting market in partnership with their competitor, suggesting...

Continue Reading
Uncovering the Baxter International Inc. Securities Fraud Case

Updated Category News Views 193

Understanding Baxter International Inc.'s Legal Landscape Baxter International Inc. (NYSE: BAX) has become a focal point for investors concerned about the integrity of its communications during a recent class action lawsuit. The Rosen Law Firm, known for advocating investor rights, is currently rallying stock purchasers of Baxter who acquired shares between specific...

Continue Reading